Home > Financial Ratios > BAL PHARMA

BAL PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   PCE(x) 8.9410.845.60-8.8512.03

What is the latest Price to Cash Earnings (PCE) ratio of BAL PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of BAL PHARMA is 8.94 based on Mar2023 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar20238.94
Mar202210.84
Mar20215.60
Mar2020-8.85
Mar201912.03

How is Price to Cash Earnings (PCE) of BAL PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2023 8.94
-17.53
Mar2022 10.84
93.57
Mar2021 5.6
Positive
Mar2020 -8.85
Negative
Mar2019 12.03 -

Other Financial Ratios of BAL PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹160.5 Cr -1.7% -1.3% 16.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹365,071.0 Cr 0.2% -6.1% 55.7% Stock Analytics
CIPLA ₹111,808.0 Cr -2.5% -5.1% 48.6% Stock Analytics
DIVIS LABORATORIES ₹104,300.0 Cr -0.9% 5% 19.2% Stock Analytics
ZYDUS LIFESCIENCES ₹101,202.0 Cr 1.8% 2.2% 88.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,035.0 Cr -3.7% -1.4% 26% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-1.7%

-1.3%

16.9%

SENSEX

-1.4%

-0.6%

20.1%


You may also like the below Video Courses